Jacqueline Reyes Diaz
Pediatric Endocrinology · Corpus Christi, TXNPI 1962819573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,341 and has fallen 96.2% since, to $50 in 2025.
Across 110 payments — averaging $30.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$704
- AbbVie$274
- Tolmar, Inc.$267
- Ascendis Pharma Endocrinology Inc$265
- Kyowa Kirin, Inc.$232
- GSK$200
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,28797%
- Education$973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $704 |
| AbbVie | 16 | $274 |
| Tolmar, Inc. | 7 | $267 |
| Ascendis Pharma Endocrinology Inc | 8 | $265 |
| Kyowa Kirin, Inc. | 5 | $232 |
| GSK | 3 | $200 |
| Abbott | 7 | $160 |
| Dexcom, Inc. | 8 | $148 |
| Xeris Pharmaceuticals, Inc. | 2 | $144 |
| Sanofi | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| AstraZeneca | 1 | $112 |
| Insulet Corporation | 5 | $85 |
| Ultragenyx Pharmaceutical Inc. | 1 | $85 |
| BETA Bionics, Inc. | 2 | $68 |
| Tolmar Pharmaceuticals, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $51 |
| Biomarin Pharmaceutical Inc. | 2 | $50 |
| Medtronic | 1 | $49 |
| Rhythm Pharmaceuticals, Inc. | 2 | $48 |
| Eton Pharmaceuticals, Inc. | 2 | $47 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,384 in reported general payments places this provider in the 70th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Corpus Christi
- Ana PaezCorpus Christi$4K
- Rajan SenguttuvanCorpus Christi$4K
- Erica Maris WeeCorpus Christi$2K
- Beatriz BlinovCorpus Christi$2K
- Jose Gamez-GodoyEdinburg$207K
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Amy BurtonPlano$130K
- Susan NunezAustin$91K
- Hector GranadosEl Paso$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.